Elevated expression of LSD1 (Lysine-specific demethylase 1) during tumour progression from pre-invasive to invasive ductal carcinoma of the breast

Overview of attention for article published in BMC Clinical Pathology, August 2012

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#13 of 117)
Good Attention Score compared to outputs of the same age (77th percentile)
Good Attention Score compared to outputs of the same age and source (75th percentile)

Mentioned by

patent: 7 patents

Readers on

mendeley: 44 Mendeley

Summary Patents

So far, Altmetric has seen 7 patents that reference this research output.

CYCLOPROPYLAMINES AS LSD1 INHIBITORS

Application EP-3626714-A1

European Patent Office

HETEROCYCLIC COMPOUNDS AS LSD1 INHIBITORS

Application EP-3626720-A1

European Patent Office

CYCLOPROPYLAMINES AS LSD1 INHIBITORS

Application EP-3626713-A1

European Patent Office

SALTS OF AN LSD1 INHIBITOR AND PROCESSES FOR PREPARING THE SAME

Application WO-2020047198-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity, including 3 additional patents.